Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT03818802 · Healthy Elderly Volunteers
NCT06435078 · Healthy Elderly, Alzheimer Disease
NCT03536871 · Sarcopenia, Healthy Elderly, and more
NCT04197661 · Healthy Elderly Subjects
NCT02440100 · Healthy Adult Subjects and Healthy Elderly Subjects
Research Site
Glendale, California
Research Site
Long Beach, California
Research Site
Panorama City, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions